explore -WSS

explore

author：comprehensive 2025-08-31 01:56:32 - browse：37464

BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning.

A few senior leaders are expected to depart as part of the reorganization. Chief Science Officer Cartier Esham, Chief Public Affairs and Marketing Officer Rich Masters, and Chief Policy Officer John Murphy are expected to leave, four sources said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Diabetes management: Digital health tools fall short, study says

leisure time

WSS

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

TB outbreak tied to bone grafts underscores testing shortcomings

Who are the detained American citizens released from prison in Iran?

Who are the detained American citizens released from prison in Iran?

Who are the detained American citizens released from prison in Iran?

Pfizer, Moderna say biotech, pharma drug development is a sprint

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

An innovative path out of biotech’s “valley of death”

The high cost of giving birth even with insurance

Covid's long

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Maui funeral service workers on devastation of fires: 'I'm in shock'

Walensky prepares to leave CDC — and Congress — behind

GOP presidential candidates start declaring their loyalty

Sports medicine is finally prioritizing gender equality

The history of OxyContin, told through Purdue Pharma documents

explore

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Target recalls 2.2 million additional candles due to laceration, burn hazards

Genentech weighs delaying cancer therapy after drug pricing law

Chinese researcher claims birth of first gene

Large hospital system sues Multiplan for low

entertainment

entertainment

leisure time

hotspot